Hearing Impairment, Sensorineural
Conditions
Keywords
cochlear implantation, electrocochleography
Brief summary
The main purpose of this study is to monitor the response from the cochlea as the electrode is inserted during the operation to receive a cochlear implant. The Cochlear Response Telemetry tool aims to measure the response from the cells within the cochlea and may be useful in the future to help to improve the surgical technique and potentially help surgeons better preserve any natural hearing that is available. The measurements are obtained using the cochlear implant and sound processor while a sound is presented to the ear through an earphone (like an earplug) placed into the ear canal.
Interventions
Study involves measuring using Electrocochleography to measure the CM response in patients undergoing cochlear implant surgery
Sponsors
Study design
Eligibility
Inclusion criteria
* Candidate for cochlear implantation (with CI522, CI532, CI622, CI632 or Hybrid-L24 (US only) according to local indications * 18 years of age or older at the time of enrolment * Pre-operative audiometric threshold in the implanted ear at 500 Hz of better than or equal to 80 dB HL * Willingness to participate in and to comply with all requirements of the protocol
Exclusion criteria
* Prior cochlear implantation in the ear to be implanted * Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array * Abnormal cochlear/nerve anatomy on pre-operative CT or MRI imaging (excluding a mild Mondini malformation or Large Vestibular Aqueduct Syndrome) * Deafness due to lesions of the acoustic nerve or central auditory pathway * Diagnosis of auditory neuropathy * Active middle-ear infection * Additional handicaps that would prevent participation in evaluations * Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure and investigational device
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Low-frequency Hearing Thresholds Assessed Audiometrically Pre- and Post-operatively. | Baseline measurement (pre-operatively) compared to 4 to 6 weeks post-surgery | Average low-frequency (LF) hearing thresholds (average thresholds at 500, 750, and 1000 Hz) will be measured for the implanted ear 4 to 6 weeks following surgery and compared with average LF hearing thresholds measured relative to the pre-operative baseline measured within 90 days of CI surgery. The outcome measure of interest is the change in average LF hearing thresholds pre- to postoperative for each subject. The average change observed for individual subjects will then be compared with individual electrophysiological cochlear microphonic (CM) measures made during the surgery using the Cochlear Response Telemetry System. Of specific interest is whether or not compromised CM measures relate to pre-to-postoperative changes in low-frequency hearing. In other words, are larger changes in average LF hearing thresholds observed in subjects with compromised CM measures made intraoperative versus those with uncompromised CM response? |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Low-frequency Hearing Thresholds Assessed Audiometrically Pre- and Post-operatively. | Baseline (pre-operative) compared to 3 months post cochlear implant activation | Average low-frequency (LF) hearing thresholds (average thresholds at 500, 750, and 1000 Hz) will be measured for the implanted ear 3 months following cochlear implant activation and compared with average LF hearing thresholds measured preoperatively. The outcome measure of interest is the change in average LF hearing thresholds pre- to postoperative for each subject. The average change observed for individual subjects will then be compared with individual electrophysiological cochlear microphonic (CM) measures made during the surgery using the Cochlear Response Telemetry System. Of specific interest is whether or not compromised CM measures relate to pre-to-postoperative changes in low-frequency hearing. In other words, are larger changes in average LF hearing thresholds observed in subjects with compromised CM measures made intraoperative versus those with uncompromised CM response. |
| Correlation of Preoperative High-frequency Hearing Thresholds and Cochlear Microphonic Response (Number of Electrodes Inserted When CM Detected). | Intraoperative | The onset of the cochlear microphonic (CM) response will be measured intraoperative to determine if there is a relationship between the onset of the CM response during electrode insertion and the preoperative high-frequency acoustic hearing thresholds. The onset of the CM response will be tracked by impedance measures that are interleaved with the CM recordings. As each electrode in the array enters the perilymph in the cochlea there will be a measured reduction in impedance. CM onset will be defined in terms of the nth electrode (out of the 22 electrodes) to enter the cochlea. Preoperative high-frequency hearing will be defined as the average of preoperative thresholds at frequencies of 2 kHz, 3 kHz and 4 kHz for each individual subject. |
Countries
Argentina
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Adults Implanted With CI522, CI532, CI622, CI632 or Hybrid-L24 (US Only) Adults (≥ 18 years of age) implanted with CI522, CI532, CI622, CI632 or Hybrid-L24 (US only) with pre-operative audiometric threshold in the ear to be implanted of better than or equal to 80 dB HL at the frequency of 500 Hz. | 61 |
| Total | 61 |
Baseline characteristics
| Characteristic | Adults Implanted With CI522, CI532, CI622, CI632 or Hybrid-L24 (US Only) | — |
|---|---|---|
| AETIOLOGY Chronic Otitis Media | 1 participants | — |
| AETIOLOGY DeaFNess Autosomal Dominant 9 (DFNA9) | 1 participants | — |
| AETIOLOGY Genetic | 8 participants | — |
| AETIOLOGY Meniere's Disease | 1 participants | — |
| AETIOLOGY Noise Exposure | 4 participants | — |
| AETIOLOGY Otosclerosis | 2 participants | — |
| AETIOLOGY Sudden Hearing Loss | 2 participants | — |
| AETIOLOGY Unknown | 39 participants | — |
| AETIOLOGY Usher's Syndrome | 3 participants | — |
| Age, Categorical <=18 years | 0 Participants | — |
| Age, Categorical >=65 years | 25 Participants | — |
| Age, Categorical Between 18 and 65 years | 36 Participants | — |
| Age, Continuous | 59.7 Years | — |
| Age of diagnosis Severe -Profound Hearing Loss | 46.98 Years | — |
| Age of onset of hearing loss | 30.75 Years | — |
| Device CI522/522 | 52 participants | — |
| Device CI532 | 9 participants | — |
| EAR (Left/Right Left Ear | 31 participants | — |
| EAR (Left/Right Right Ear | 30 participants | — |
| Nature of Hearing loss CONGENITAL WITH PROGRESSION | 8 participants | — |
| Nature of Hearing loss No Data | 1 participants | — |
| Nature of Hearing loss PROGRESSION WITH SUDDEN | 1 participants | — |
| Nature of Hearing loss PROGRESSIVE | 47 participants | — |
| Nature of Hearing loss SUDDEN | 4 participants | — |
| Race and Ethnicity Not Collected | — | — Participants |
| Sex: Female, Male Female | 35 Participants | — |
| Sex: Female, Male Male | 26 Participants | — |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 61 |
| other Total, other adverse events | 15 / 61 |
| serious Total, serious adverse events | 2 / 61 |
Outcome results
Change in Low-frequency Hearing Thresholds Assessed Audiometrically Pre- and Post-operatively.
Average low-frequency (LF) hearing thresholds (average thresholds at 500, 750, and 1000 Hz) will be measured for the implanted ear 4 to 6 weeks following surgery and compared with average LF hearing thresholds measured relative to the pre-operative baseline measured within 90 days of CI surgery. The outcome measure of interest is the change in average LF hearing thresholds pre- to postoperative for each subject. The average change observed for individual subjects will then be compared with individual electrophysiological cochlear microphonic (CM) measures made during the surgery using the Cochlear Response Telemetry System. Of specific interest is whether or not compromised CM measures relate to pre-to-postoperative changes in low-frequency hearing. In other words, are larger changes in average LF hearing thresholds observed in subjects with compromised CM measures made intraoperative versus those with uncompromised CM response?
Time frame: Baseline measurement (pre-operatively) compared to 4 to 6 weeks post-surgery
Population: 19 of the 80 ECochG intro-operative responses were excluded from the analysis (reasons are outlined in the CIR). A further 18 of the remaining 61 data points were excluded due to an unclear CM response resulting in N=43 responses categorized as either preserved or compromised. Further, two subjects were excluded from the primary endpoint analysis as there were no FUV1 thresholds collected. Thereby N=41.
| Arm | Measure | Value (MEAN) |
|---|---|---|
| Cochlear Implant Recipients | Change in Low-frequency Hearing Thresholds Assessed Audiometrically Pre- and Post-operatively. | 26.9 dB |
Change in Low-frequency Hearing Thresholds Assessed Audiometrically Pre- and Post-operatively.
Average low-frequency (LF) hearing thresholds (average thresholds at 500, 750, and 1000 Hz) will be measured for the implanted ear 3 months following cochlear implant activation and compared with average LF hearing thresholds measured preoperatively. The outcome measure of interest is the change in average LF hearing thresholds pre- to postoperative for each subject. The average change observed for individual subjects will then be compared with individual electrophysiological cochlear microphonic (CM) measures made during the surgery using the Cochlear Response Telemetry System. Of specific interest is whether or not compromised CM measures relate to pre-to-postoperative changes in low-frequency hearing. In other words, are larger changes in average LF hearing thresholds observed in subjects with compromised CM measures made intraoperative versus those with uncompromised CM response.
Time frame: Baseline (pre-operative) compared to 3 months post cochlear implant activation
Population: 5 data points were excluded from this analysis due to post-operative thresholds not being measured at FUV2 (43 - 5 = 38).
| Arm | Measure | Value (MEAN) |
|---|---|---|
| Cochlear Implant Recipients | Change in Low-frequency Hearing Thresholds Assessed Audiometrically Pre- and Post-operatively. | 31.52 dB |
Correlation of Preoperative High-frequency Hearing Thresholds and Cochlear Microphonic Response (Number of Electrodes Inserted When CM Detected).
The onset of the cochlear microphonic (CM) response will be measured intraoperative to determine if there is a relationship between the onset of the CM response during electrode insertion and the preoperative high-frequency acoustic hearing thresholds. The onset of the CM response will be tracked by impedance measures that are interleaved with the CM recordings. As each electrode in the array enters the perilymph in the cochlea there will be a measured reduction in impedance. CM onset will be defined in terms of the nth electrode (out of the 22 electrodes) to enter the cochlea. Preoperative high-frequency hearing will be defined as the average of preoperative thresholds at frequencies of 2 kHz, 3 kHz and 4 kHz for each individual subject.
Time frame: Intraoperative
Population: 40 data points with a CM response were eligible to be analysed for this outcome. Those excluded were due to an absence of CM under visual inspection (n =16), an absence of the impedance measurement used to calculate depth (n = 4), or an array that was withdrawn or reinserted at any time (n = 5).
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Cochlear Implant Recipients | Correlation of Preoperative High-frequency Hearing Thresholds and Cochlear Microphonic Response (Number of Electrodes Inserted When CM Detected). | 0.78 Pearson correlation coefficient |